# Conmana Combined With Thalidomide to Treat NSCLC

> **NCT02778893** · PHASE4 · UNKNOWN · sponsor: **Henan Provincial People's Hospital** · enrollment: 67 (estimated)

## Conditions studied

- NSCLC

## Interventions

- **DRUG:** Conmana
- **DRUG:** Thalidomide

## Key facts

- **NCT ID:** NCT02778893
- **Lead sponsor:** Henan Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03
- **Primary completion:** 2017-03
- **Final completion:** 2020-03
- **Target enrollment:** 67 (ESTIMATED)
- **Last updated:** 2016-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02778893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02778893, "Conmana Combined With Thalidomide to Treat NSCLC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02778893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*